Your browser doesn't support javascript.
loading
Cachexia: A systemic consequence of progressive, unresolved disease.
Ferrer, Miriam; Anthony, Tracy G; Ayres, Janelle S; Biffi, Giulia; Brown, Justin C; Caan, Bette J; Cespedes Feliciano, Elizabeth M; Coll, Anthony P; Dunne, Richard F; Goncalves, Marcus D; Grethlein, Jonas; Heymsfield, Steven B; Hui, Sheng; Jamal-Hanjani, Mariam; Lam, Jie Min; Lewis, David Y; McCandlish, David; Mustian, Karen M; O'Rahilly, Stephen; Perrimon, Norbert; White, Eileen P; Janowitz, Tobias.
Afiliación
  • Ferrer M; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; MRC Cancer Unit, University of Cambridge, Hutchison Research Centre, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK.
  • Anthony TG; Department of Nutritional Sciences, Rutgers School of Environmental and Biological Sciences, The State University of New Jersey, New Brunswick, NJ 08901, USA.
  • Ayres JS; Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
  • Biffi G; University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
  • Brown JC; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.
  • Caan BJ; Kaiser Permanente Northern California Division of Research, Oakland, CA 94612, USA.
  • Cespedes Feliciano EM; Kaiser Permanente Northern California Division of Research, Oakland, CA 94612, USA.
  • Coll AP; Wellcome Trust-MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Dunne RF; University of Rochester Medical Center, University of Rochester, Rochester, NY 14642, USA.
  • Goncalves MD; Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
  • Grethlein J; Ruprecht Karl University of Heidelberg, Heidelberg 69117, Germany.
  • Heymsfield SB; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.
  • Hui S; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
  • Jamal-Hanjani M; Department of Medical Oncology, University College London Hospitals, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK.
  • Lam JM; Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK.
  • Lewis DY; The Beatson Institute for Cancer Research, Cancer Research UK, Glasgow G61 1BD, UK.
  • McCandlish D; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Mustian KM; University of Rochester Medical Center, University of Rochester, Rochester, NY 14642, USA.
  • O'Rahilly S; Wellcome Trust-MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Perrimon N; Department of Genetics, Blavatnik Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.
  • White EP; Rutgers Cancer Institute of New Jersey, Department of Molecular Biology and Biochemistry, Rutgers University, The State University of New Jersey, New Brunswick, NJ 08901, USA; Ludwig Princeton Branch, Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ 08544, USA.
  • Janowitz T; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; Northwell Health Cancer Institute, Northwell Health, New Hyde Park, NY 11042, USA. Electronic address: janowitz@cshl.edu.
Cell ; 186(9): 1824-1845, 2023 04 27.
Article en En | MEDLINE | ID: mdl-37116469
Cachexia, a systemic wasting condition, is considered a late consequence of diseases, including cancer, organ failure, or infections, and contributes to significant morbidity and mortality. The induction process and mechanistic progression of cachexia are incompletely understood. Refocusing academic efforts away from advanced cachexia to the etiology of cachexia may enable discoveries of new therapeutic approaches. Here, we review drivers, mechanisms, organismal predispositions, evidence for multi-organ interaction, model systems, clinical research, trials, and care provision from early onset to late cachexia. Evidence is emerging that distinct inflammatory, metabolic, and neuro-modulatory drivers can initiate processes that ultimately converge on advanced cachexia.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Caquexia Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Caquexia Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article